Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for pharmaceutical industry professionals · Saturday, October 1, 2022 · 593,670,275 Articles · 3+ Million Readers

Global Longevity and Anti-Senescence Therapy Market Assessment worth $ 41.10 Billion by 2030 - by InsightAce Analytic

Global Longevity and Anti-Senescence Therapy Market info

Global Longevity and Anti-Senescence Therapy Market info

Global Longevity and Anti-Senescence Therapy Market segment

Global Longevity and Anti-Senescence Therapy Market segment

Global Longevity and Anti-Senescence Therapy market is valued at US$ 25.33 billion in 2021, and it is expected to reach US$ 41.10 billion by 2030

Major market players operating in the Longevity and Anti-Senescence Therapy market include Powervision Inc., Prana Biotechnology Ltd., Proteostasis Therapeutics Inc., Recursion Pharmaceuticals”
— Insightace Analytic

NEW JERSEY, SATTE NJ, COUNTRY USA, August 19, 2022 /EINPresswire.com/ -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Longevity and Anti-Senescence Therapy Market- by Therapy (Senolytic Drug Therapy, Gene Therapy, Cell Therapy, Mitochondrial Therapy, Immunotherapy, and Others), Application (Longevity, Senescence Inhibition, Cardiovascular Diseases, Neural Degenerative Diseases, Ophthalmology Disorders, and Cancer), Trends, Industry Competition Analysis, Revenue and Forecast To 2030."

Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1354

According to the latest research by InsightAce Analytic, the global Longevity and Anti-Senescence Therapy market is valued at US$ 25.33 billion in 2021, and it is expected to reach US$ 41.10 billion by 2030, with a CAGR of 5.8% during a forecast period of 2022-2030.

The goal of longevity and anti-senescence therapies is to offer therapeutic choices to counteract chronic illnesses and functional deficits associated with ageing. Research on the molecular causes of ageing has changed the way we think about and approach treating and preventing ageing during the past two decades. By accelerating and enhancing the development of ageing research and therapies addressing age-related disorders, this initiative aims to improve human longevity. Pharmacological treatments, molecular (genetic and epigenetic), lifestyle-related, and cellular therapies can all be grouped together under the heading of longevity and anti-senescence therapy.

The rise in chronic illness prevalence, the increased consumer awareness of anti-aging products, and developments in AI-driven medical technology are all factors driving the expansion of the longevity and anti-senescence therapy industry. Additionally, the market is expected to develop as the number of elderly people and the desire for individualised, accurate, preventive, and participative ageing treatments both rise. The lack of qualified workers and diminished tissue repair capability, however, are anticipated to impede market expansion. Contrarily, the growth of the longevity and anti-senescence therapy industries is predicted to be aided by the rise in demand for cell-based assays in R&D. The shutdown of numerous industrial sites and problems with product delivery caused by lockdown measures used during the Covid-19 outbreak led to the supply-demand gap. This resulted in lower sales of longevity products, which in turn restrained the market's expansion for longevity and anti-senescence therapy.

North America is anticipated to be the major contributor to the Longevity and Anti-Senescence Therapy market over the forecast years. This is attributed to an increase in the prevalence of chronic heart diseases, a rise in anti-ageing product demand, an increase in the accessibility of high-tech healthcare facilities with qualified medical staff, an upsurge in the number of R&D activities with the presence of key players, and an expansion in government investments in the healthcare system. In addition, the Asia Pacific Longevity and Anti-Senescence Therapy market is expected to grow significantly during the forecast period due to the growth of the R&D sector, rise in healthcare reforms, improvement in healthcare infrastructure, rise in the number of hospitals with advanced equipment, and technical breakthroughs in the longevity and anti-Senescence therapy market projection.

Major market players operating in the Longevity and Anti-Senescence Therapy market include Powervision Inc., Prana Biotechnology Ltd., Proteostasis Therapeutics Inc., Recursion Pharmaceuticals, Restorbio, Sierra Sciences Llc, Senex Biotechnology, Senolytic Therapeutics, Spotlight Bioscience, Acorda Therapeutics, Agex Therapeutics, Antoxerene, Calico Life Sciences, Celgene, Cleara Biotech, Human Longevity Inc., Insilico Medicine, Oisin Biotechnology, T.A. Sciences, Lineage Cell Therapeutics, Juvenescence Life, Longevity Biotech CohBar, Inc. (CBR), Genome Protection Inc., Navitor Pharmaceuticals, Inc., Elevian, Inc., Unity Biotechnology, Alkahest, Inc., Stealth BioTherapeutics, BIOPHYTIS BSA, SIWA Therapeutics, Rejuveron Life Sciences AG, Rubedo Life Sciences, Inc, and Other Prominent Players.

Recent collaborations and agreements in the market:
• In January 2019, the results of a trial in which 14 patients with the fatal lung ailment Idiopathic Pulmonary Fibrosis (IPF) were treated with a combination of medications that researchers anticipated would wipe away senescent cells were published by University of Texas researchers.

Curious about this latest version of the report? Obtain Report Details @ https://www.insightaceanalytic.com/enquiry-before-buying/1354

Market Segments
Global Longevity and Anti-Senescence Therapy Market, by Therapy, 2022-2030 (Value US$ Mn)
• Senolytic Drug Therapy
• Gene Therapy
• Cell Therapy
• Mitochondrial Therapy
• Immunotherapy
• Others

Global Longevity and Anti-Senescence Therapy Market, by Distribution Channel, 2022-2030 (Value US$ Mn)
• Longevity
• Senescence Inhibition
• Cardiovascular Diseases
• Neural Degenerative Diseases
• Ophthalmology Disorders
• Cancer

Global Longevity and Anti-Senescence Therapy Market, by Region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

North America Longevity and Anti-Senescence Therapy Market, by Country, 2022-2030 (Value US$ Mn)
• U.S.
• Canada

Europe Longevity and Anti-Senescence Therapy Market, by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe

Asia Pacific Longevity and Anti-Senescence Therapy Market, by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand

Latin America Longevity and Anti-Senescence Therapy Market, by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa Longevity and Anti-Senescence Therapy Market, by Country, 2022-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa

Why should buy this report:
 To receive a comprehensive analysis of the prospects for the global Longevity and Anti-Senescence Therapy market
 To receive an industry overview and future trends of the Longevity and Anti-Senescence Therapy market
 To analyze the Longevity and Anti-Senescence Therapy market drivers and challenges
 To get information on the Longevity and Anti-Senescence Therapy market value (US$Mn) forecast to 2030
 To get information on investments, mergers & acquisitions in the Longevity and Anti-Senescence Therapy market industry

For More Customization @ https://www.insightaceanalytic.com/customisation/1354

Priyanka Tilekar
Insightace Analytic Pvt. Ltd.
+1 551-226-6109
email us here

Powered by EIN Presswire
Distribution channels: Healthcare & Pharmaceuticals Industry


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release